Health

Linvoseltamab Promising in High-Risk Smoldering Multiple Myeloma

TribeNews
By TribeNews 1 View Add a Comment
0 Min Read
Linvoseltamab Promising in High-Risk Smoldering Multiple Myeloma

MedPage Today) — TORONTO — Linvoseltamab (Lynozyfic) appeared effective in patients with high-risk smoldering multiple myeloma (HR-SMM), according to preliminary phase II trial data.
With a median follow-up of 3.9 months among 19 evaluable…

Leave a Comment
Ads Blocker Image Powered by Code Help Pro

Ads Blocker Detected & This Is Prohibited!!!

We have detected that you are using extensions to block ads and you are also not using our official app. Your Account Have been Flagged and reported, pending de-activation & All your earning will be wiped out. Please turn off the software to continue

You cannot copy content of this app